Spheroid Culture: The Complete End-to-End Guide
From fundamentals to ready-to-use protocols — methods, serum selection, OLS CERO 3D technology, zenCELL owl live imaging, and custom media for reproducible 3D cell culture in research and industry. All materials from EU stock, no MOQ, batch reservation.
What Are Spheroids & Why Use 3D Cell Culture?
Spheroids are three-dimensional, multicellular aggregates that mimic the in-vivo cell environment far more accurately than conventional 2D monolayer cultures. They reproduce cell-cell and cell-matrix interactions as well as diffusion gradients that simply do not exist in flat culture vessels.
In tumour research, spheroids reflect the architecture of solid tumours — with a proliferating outer layer, quiescent intermediate zone, and necrotic core. In drug research they provide more valid results for dose-finding and penetration studies. For ATMP and stem cell applications, spheroids allow cultivation of iPSC, organotypic structures, and tissue models without embedding substrate — a decisive advantage for GMP-regulated processes.
| Parameter | 2D Monolayer | 3D Spheroid |
|---|---|---|
| Cell-cell contact | Limited | Complete |
| In-vivo relevance | Low | High |
| Diffusion gradients | None | Present — O₂, nutrient, drug |
| Drug penetration | Simplified — all cells exposed equally | Realistic — gradient penetration |
| Necrotic core | Not present | Develops at >200 µm diameter |
| Drug resistance modelling | Underestimates resistance | Closer to clinical IC₅₀ |
| GMP suitability | Limited | Excellent — scaffold-free options |
| Continuous monitoring | Manual endpoint only | zenCELL owl — 24/7 in-incubator |
4 Main Spheroid Cultivation Methods
Ultra-Low Attachment (ULA)
Cells are cultured in non-adherent well plates. Absence of adhesion drives aggregation into spheroids. Simplest method, highly scalable for high-throughput screening. Compatible with zenCELL owl for continuous monitoring.
Concentration: 2–5% FBS — low serum promotes compact spheroid formation
Hanging Drop Method
Drops with a defined cell number are cultured inverted. Gravity drives aggregation. Maximum control over spheroid size — ideal for defined tumour spheroid models, hepatospheres, and cardiac aggregates where precise sizing is critical.
Concentration: 5–10% — slightly higher supports drop stability without losing compaction
Rotating Bioreactors (OLS CERO 3D)
Dynamic suspension through rotation prevents cell adhesion. Suitable for scale-up, ATMP production, and long-term cultivation over weeks to months. OLS CERO 3D is the reference — no shear forces, scaffold-free, full environmental control.
Microwell / Scaffold-Based
Microwell plates define size and shape precisely. Highest homogeneity for standardised assays, organoid cultures, and tissue engineering models. Required when spheroid size coefficient of variation must be <10%.
OLS CERO 3D — Gentle Cultivation Without Shear Forces
The OLS CERO 3D Incubator & Bioreactor by OMNI Life Science is the reference technology for reproducible spheroid and organoid cultivation. Scaffold-free, no embedding substrate, minimal hands-on time (<2 min/day).
Available exclusively in DACH via SeamlessBio and innoME. Bundle with OrganoMedium™ and zenCELL owl available.
- No shear forces — gentle rotation via CERO-Tubes, minimised apoptosis and necrosis, maximum viability
- No embedding substrate required — scaffold-free cultivation without Matrigel, ideal for GMP processes
- Full environmental control — temperature, pH and CO₂ continuously monitored
- Long-term cultivation over 1 year — highest spheroid viability for resistance studies
- iPSC and organoid compatible — including brain, intestinal, cardiac organoids
- GMP-adjacent — closed tube system, no embedding substrate eliminates Matrigel from process
Serum Selection by Spheroid Type & Application
| Spheroid Type | Anwendung | Recommended Serum | Concentration & Rationale |
|---|---|---|---|
| Tumour spheroids — standard | Drug cytotoxicity IC₅₀, proliferation, penetration studies | FBS Low Endotoxin <1 EU/mL | 2–5% — low serum promotes tight spheroid with hypoxic core that mimics solid tumour. Endotoxin activates TLR4 on tumour cells → altered drug sensitivity. |
| Tumour spheroids — ADCC assays | Anti-tumour mAb ADCC on 3D spheroid targets | FBS Ultra Low IgG <5 µg/mL | 2–5% — bovine IgG at 200–800 µg/mL in standard FBS blocks FcγRIII on NK cells, reducing measured ADCC signal on spheroid targets. |
| Hepatospheres (HepG2, HepaRG) | DILI modelling, hepatotoxicity, metabolic studies | FBS Low Endotoxin <1 EU/mL | 2–5% — endotoxin activates hepatoma innate immune responses, confounding DILI readout. Low Endotoxin is minimum for hepatic spheroid assays. |
| Intestinal spheroids | Drug absorption, permeability, gut barrier | OrganoMedium™ Intestinal or FBS Low Endotoxin 2–5% | Patient-derived: OrganoMedium™ serum-free. Caco-2/HT-29 spheroids: FBS Low Endotoxin 2–5%. |
| Cardiac spheroids / aggregates | Cardiotoxicity, force generation, arrhythmia | FBS Low Endotoxin <1 EU/mL | 2% maintenance — high serum inhibits cardiomyocyte contractility. zenCELL owl captures contraction as quality indicator in brightfield timelapse. |
| iPSC-derived spheroids | Disease modelling, drug screening | OrganoMedium™ Brain/Base or serum-free N2/B27 | Serum drives astrocyte differentiation — serum-free required for neural. OrganoMedium™ provides defined organoid-specific conditions. |
| ATMP / stem cell spheroids (GMP) | iPSC, organotypic, tissue models without embedding substrate | FBS ES-Zelle, vorab getestet → OrganoMedium™ | ES Cell Pre-Tested for EB stage; OrganoMedium™ serum-free for directed differentiation. CERO 3D for long-term GMP-adjacent spheroid culture. |
zenCELL owl — Live Spheroid Monitoring Inside the Incubator
zenCELL owl provides 24 channels of brightfield imaging directly inside the incubator — monitoring spheroid growth, morphology, and drug response continuously from seeding to endpoint without ever removing samples. Compatible with all 4 spheroid cultivation methods described above.
| Anwendung | zenCELL owl Function | Key Advantage vs Manual |
|---|---|---|
| Spheroid growth monitoring | Automated size tracking, growth curves from day 1 to endpoint | Continuous data — no sampling disruption, no thermal shock |
| Drug response kinetics | Time-resolved morphology during and after treatment | When did response begin? Is it reversible? Endpoint assays cannot answer these. |
| HTS drug screening | 96/384-well ULA plate compatible — full automation | True high-throughput spheroid imaging without confocal infrastructure |
| Cardiac aggregate contractility | Brightfield timelapse captures rhythmic contraction | Non-invasive functional assessment without calcium dyes |
| Long-term CERO 3D cultures | Transfer to 96-well for zenCELL owl imaging, return to CERO 3D | Non-destructive quality assessment during long-term bioreactor runs |
Validated Protocols
Protocol 1 — ULA 96-well Compact Tumour Spheroid (Day 1–3)
1. Trypsinise adherent cells, count, adjust to 1,000–5,000 cells/mL in RPMI/DMEM + 2% FBS Low Endotoxin <1 EU/mL.
2. Dispense 200 µL/well (200–1,000 cells/well) into U-bottom ULA 96-well plate.
3. Centrifuge 300 × g, 3 min — accelerates initial aggregation.
4. Incubate 37°C, 5% CO₂. Compact spheroids form in 24–72h.
5. Half-medium change from day 3 — maintain 2% FBS Low Endotoxin throughout.
Monitor: zenCELL owl timelapse from seeding captures aggregation kinetics and growth rate continuously without disruption.
Protocol 2 — AlamarBlue Viability on Spheroids (Day 5–7 endpoint)
1. Add test compound in 2% FBS Low Endotoxin — identical serum % in ALL wells including vehicle and maximum kill controls.
2. Treat 48–72h at 37°C.
3. Add AlamarBlue at 1:10 volume directly to well — no wash, no spheroid disruption.
4. Incubate 4–6h (longer than monolayer — reagent must penetrate spheroid core).
5. Read fluorescence (Ex 560 / Em 590 nm). Subtract serum-only blank.
% Viability = (test − blank) / (vehicle − blank) × 100
Protocol 3 — CERO 3D Long-Term Spheroid Culture
1. Seed cells at 5×10⁵–2×10⁶ cells/tube in 15–35 mL OrganoMedium™ or 2–5% FBS Low Endotoxin.
2. Set rotation speed per cell type (10–20 rpm). Incubate 37°C, 5% CO₂.
3. Change 50% medium every 2–3 days — gentle removal to avoid disturbing aggregates.
4. For imaging: transfer to ULA 96-well for zenCELL owl assessment, return to CERO 3D.
Result: No shear forces → intact spheroids. No matrix → easy harvest. Weeks to months culture without fragmentation.
Frequently Asked Questions
Request Free Samples for Spheroid Assay Validation
FBS Low Endotoxin and Ultra Low IgG samples. Lot-specific endotoxin data. zenCELL owl demo. OrganoMedium™ for serum-free spheroid protocols.
Email: info@seamlessbio.de | +49 851 37932226
English 
Deutsch